IP Library Granted Patent US 10,889,785
Granted Patent B2
US 10,889,785 · App. 15/945,131 · Granted Jan 12, 2021

Compositions and methods for reducing cat allergens in the environment

Inventors: George Wells (St. Louis, MO); Delphine Tissot-Favre (Gollion, CH); Ebenezer Satyaraj (Wildwood, MO); Juergen Eck (Bensheim, DE); Daniel Meyer (Schenkon, CH); Torsten Ertongur-Fauth (Darmstadt, DE); Alexander Pelzer (Bickenach, DE); Scott Sherrill (Chesterfield, MO); Peichuan Sun (St. Louis, MO)
Assignee: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
C11D3/38609A01K1/0155A23K20/189A23K50/40A23K50/42A23K50/48A61L9/00C11D3/386C11D3/38618C11D11/0011A61K38/00C12Y304/21062
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,889,785
App. No.
15/945,131
Granted
Jan 12, 2021
Kind
B2
Abstract

Formulations, compositions and products for reducing allergenic Fel d 1 from the environment are disclosed. The formulations include at least one protease that interacts with the Fel d 1 and substantially degrades allergenic epitopes on the Fel d 1. Methods of using the formulations for reducing or eliminating allergenic Fel d 1 from the environment are also disclosed.

Claims (13)

1. A formulation disposed in a cat litter in an amount effective for reducing or eliminating allergenic Fel d 1 from an environment, the formulation comprising a serine protease comprising a subtilisin from at least one species of Bacillus selected from the group consisting of B. licheniformis, B. clausii, B. haloudurans, B. lentus, B. amyloliquefaciens , and B. subtilis , wherein the subtilisin interacts with the Fel d 1 degrades allergenic epitopes on the Fel d 1, wherein the cat litter comprises perlite to which the subtilisin is cross-linked.

2. The formulation of claim 1 , wherein the subtilisin is cross-linked to the perlite by a diamine and a dialdehyde.

3. The formulation of claim 1 wherein the subtilisin is from B. licheniformis.

4. The formulation of claim 1 , further comprising an additive that enhances the efficiency of the subtilisin in degrading the Fel d 1, wherein the additive is cysteine or calcium salt/ions (Ca 2+ ), or a combination of cysteine and calcium salt/ions (Ca 2+ ).

5. The formulation of claim 1 , wherein the subtilisin is recognized as safe for use in foods and cosmetics.

6. The formulation of claim 5 , wherein the subtilisin has substantially no interaction with substances selected from: keratin, collagen, elastin, fibronectin, other proteins and fibers or fabric.

7. A method of reducing or eliminating allergenic Fel d 1 from the environment, comprising contacting an element of the environment where Fel d 1 is present with a formulation comprising a serine protease comprising a subtilisin from at least one species of Bacillus selected from the group consisting of B. licheniformis, B. clausii, B. haloudurans, B. lentus, B. amyloliquefaciens , and B. subtilis , wherein the subtilisin interacts with the Fel d 1 and degrades allergenic epitopes on the Fel d 1 thereby reducing or eliminating allergenic Fel d 1 from the environment.

8. The method of claim 7 , wherein the Fel d 1 is present on an inanimate surface and the formulation is applied to the surface.

9. The method of claim 7 , wherein the Fel d 1 is present in or on an animal that produces Fel d 1 and the formulation is applied to the portion of the animal on which the Fel d 1 is present.

10. The method of claim 9 , wherein the Fel d 1 is present on the hair, fur or external skin of the animal or is present in the mouth of the animal.

11. A kit comprising a cat litter comprising a formulation that includes a serine protease comprising a subtilisin from at least one species of Bacillus selected from the group consisting of B. licheniformis, B. clausii, B. haloudurans, B. lentus, B. amyloliquefaciens , and B. subtilis , wherein the subtilisin interacts with Fel d 1 degrades allergenic epitopes on the Fel d 1, and the kit further comprising instructions for use of the cat litter in reducing or eliminating allergenic Fel dl from the environment, wherein the cat litter comprises perlite to which the subtilisin is cross-linked.

12. The kit of claim 11 , wherein the subtilisin is from B. licheniformis.

13. The kit of claim 11 , wherein the subtilisin is cross-linked to the perlite by a diamine and a dialdehyde.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2019
From: WELLS, GEORGE; TISSOT-FAVRE, DELPHINE; SATYARAJ, EBENEZER; ECK, JUERGEN; MEYER, DANIEL; ERTONGUR-FAUTH, TORSTEN; PELZER, ALEXANDER; SHERRILL, SCOTT; SUN, PEICHUAN
To: NESTEC SA
Reel/Frame 047943/0255 →
Continuity (3)
Continuation 14570310 · Dec 15, 2014
Provisional Application 61918420 · Dec 19, 2013
Related Publication 20180223223A1 · Aug 9, 2018